Are Updated COVID-19 Vaccines Still Relevant for All Adult Age Groups? An Economic Evaluation of the Monovalent XBB.1.5 Vaccine in Australia
The monovalent XBB.1.5 vaccine is cost-effective and still relevant for all adult age groups in Australia. Based on current evidence, the study findings support the promotion of booster vaccination for Australian adults.
Authors
- Charles Okafor (ORCID: https://orcid.org/0000-0002-7048-910X)
- Namal N. Balasooriya (ORCID: https://orcid.org/0000-0001-5044-7386)
- Syed Afroz Keramat (ORCID: https://orcid.org/0000-0001-8747-9891)
- Echezona H Dioji
Institutions
- Queensland Health (AU)
- The University of Queensland (AU)
- Torrens University Australia (AU)
Publication Details
- Journal
- Value in Health
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1016/j.jval.2025.01.014
- Citations
- 2
- Primary Topic
- COVID-19 epidemiological studies
- Type
- article
- Field-Weighted Citation Impact
- 2.74